These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25795077)

  • 1. New effective antituberculosis regimens.
    Sotgiu G; Migliori GB
    Lancet; 2015 May; 385(9979):1703-1704. PubMed ID: 25795077
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
    Dawson R; Diacon AH; Everitt D; van Niekerk C; Donald PR; Burger DA; Schall R; Spigelman M; Conradie A; Eisenach K; Venter A; Ive P; Page-Shipp L; Variava E; Reither K; Ntinginya NE; Pym A; von Groote-Bidlingmaier F; Mendel CM
    Lancet; 2015 May; 385(9979):1738-1747. PubMed ID: 25795076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drug combination may shorten tuberculosis treatment, study says.
    Mayor S
    BMJ; 2015 Mar; 350():h1518. PubMed ID: 25788408
    [No Abstract]   [Full Text] [Related]  

  • 4. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.
    Diacon AH; Dawson R; von Groote-Bidlingmaier F; Symons G; Venter A; Donald PR; van Niekerk C; Everitt D; Winter H; Becker P; Mendel CM; Spigelman MK
    Lancet; 2012 Sep; 380(9846):986-93. PubMed ID: 22828481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.
    Zignol M; Dean AS; Alikhanova N; Andres S; Cabibbe AM; Cirillo DM; Dadu A; Dreyer A; Driesen M; Gilpin C; Hasan R; Hasan Z; Hoffner S; Husain A; Hussain A; Ismail N; Kamal M; Mansjö M; Mvusi L; Niemann S; Omar SV; Qadeer E; Rigouts L; Ruesch-Gerdes S; Schito M; Seyfaddinova M; Skrahina A; Tahseen S; Wells WA; Mukadi YD; Kimerling M; Floyd K; Weyer K; Raviglione MC
    Lancet Infect Dis; 2016 Oct; 16(10):1185-1192. PubMed ID: 27397590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TB Alliance regimen development for multidrug-resistant tuberculosis.
    Murray S; Mendel C; Spigelman M
    Int J Tuberc Lung Dis; 2016 Dec; 20(12):38-41. PubMed ID: 28240571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis.
    Nuermberger E; Tyagi S; Tasneen R; Williams KN; Almeida D; Rosenthal I; Grosset JH
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1522-4. PubMed ID: 18285479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Incidence of New-Onset Joint Pain in Patients on Fluoroquinolones as Antituberculous Treatment.
    Mandovra NP; Lele TT; Vaidya PJ; Chavhan VB; Leuppi-Taegtmeyer AB; Leuppi JD; Chhajed PN
    Respiration; 2020; 99(2):125-131. PubMed ID: 31935716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PA-824 , moxifloxacin and pyrazinamide combination therapy for tuberculosis.
    Dawson R; Diacon A
    Expert Opin Investig Drugs; 2013 Jul; 22(7):927-32. PubMed ID: 23687915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of incorporating bedaquiline into a treatment regimen for MDR/XDR-TB in Germany.
    Wolfson LJ; Gibbert J; Wirth D; Diel R
    Eur Respir J; 2015 Dec; 46(6):1826-9. PubMed ID: 26493796
    [No Abstract]   [Full Text] [Related]  

  • 11. No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.
    Cobelens F; Gebhard A; van den Hof S
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):282. PubMed ID: 26792486
    [No Abstract]   [Full Text] [Related]  

  • 12. In reply.
    Takiff H; Alame-Emane AK; Pierre-Audigier C; Gicquel B
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):282-3. PubMed ID: 26792487
    [No Abstract]   [Full Text] [Related]  

  • 13. Delamanid (Deltyba°) and multidrug-resistant pulmonary tuberculosis.
    Prescrire Int; 2017 Apr; 26(181):89-92. PubMed ID: 30730656
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in the treatment of tuberculosis.
    Zhang Y
    Clin Pharmacol Ther; 2007 Nov; 82(5):595-600. PubMed ID: 17898708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimen.
    Dutta NK; Alsultan A; Gniadek TJ; Belchis DA; Pinn ML; Mdluli KE; Nuermberger EL; Peloquin CA; Karakousis PC
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3910-6. PubMed ID: 23733473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing multidrug-resistant tuberculosis in children: review of recent developments.
    Schaaf HS; Garcia-Prats AJ; Hesseling AC; Seddon JA
    Curr Opin Infect Dis; 2014 Jun; 27(3):211-9. PubMed ID: 24751893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drug combination for TB is tested in unique trial.
    Kmietowicz Z
    BMJ; 2012 Jul; 345():e5060. PubMed ID: 22833631
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoroquinolones for the treatment of pulmonary tuberculosis.
    Moadebi S; Harder CK; Fitzgerald MJ; Elwood KR; Marra F
    Drugs; 2007; 67(14):2077-99. PubMed ID: 17883288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.
    Pierre-Audigier C; Surcouf C; Cadet-Daniel V; Namouchi A; Heng S; Murray A; Guillard B; Gicquel B
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):221-3, i-ii. PubMed ID: 22236923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Respiratory fluoroquinolones and pulmonary tuberculosis treatment when the main drugs are ineffective].
    Lazareva NB; Khaĭmenova TIu; Khaĭmenov AIa
    Antibiot Khimioter; 2008; 53(5-6):14-20. PubMed ID: 19069177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.